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Background
S h o t g u np r o t e o m i c si sap o w e r f u lt e c h n o l o g yf o rp r o -
tein identification in complex samples with remarkable
applications in elucidating cellular and subcellular pro-
teomes [1,2], and discovering disease biomarkers [3,4].
Shotgun proteomics data analysis usually relies on
database search. Commonly used protein sequence
databases in shotgun proteomics data analysis do not
contain mutation informat i o n .T h i sb e c o m e sap r o -
blem in cancer studies in which the detection of dis-
ease-related mutated peptides/proteins is crucial for
understanding cancer biology [5]. Including protein
mutation information into sequence databases can help
alleviate this problem.
Results
Based on the human Cancer Proteome Variation Data-
base developed by us recently [6], which comprises
41,541 nonsynonymous SNPs in 30,322 proteins from
the dbSNP database and around 9000 cancer-related
variations in 2,921 proteins, we created a variation-con-
taining protein sequence database and a data analysis
workflow for mutant protein identification in shotgun
proteomics (Figure 1). Applying this workflow on color-
ectal cancer cell lines identified many peptides that con-
tain either non-cancer-specific or very important
cancer-related variations, such as a known somatic
mutation in K-Ras in HCT116 cell line. Our workflow
for mutant peptide identification has been tested for
compatibility with various popular database search
engines including Sequest, Mascot, X!Tandom as well as
MyriMatch.
Conclusion
Owing to its protein-centric nature, the approach we
proposed can serve as a bridge between genomic varia-
tion data and proteomics studies in human cancer.
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